Bolt Biotherapeutics, Inc. (BOLT) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-11 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-02 | 8-K | Item 2.05, Other Events | SEC |
| 2025-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-06 | 8-K | Listing Notice, Charter Amendments | SEC |
| 2025-06-04 | 8-K | Other Events | SEC |
| 2025-05-28 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-16 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-03-24 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-03 | 8-K | Listing Notice | SEC |
| 2024-12-23 | 8-K | Officer / Director Changes | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-04 | 8-K | Officer / Director Changes | SEC |
| 2024-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-03 | 8-K | Listing Notice | SEC |
| 2024-06-14 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-14 | 8-K | Acquisition or Disposition, Item 2.05, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-03-21 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.